General Information
Pfizer NASH C3711005
A Phase 2A, 2-Part, Randomized, Double-Blind, Double-Dummy Placebo-Controlled, Parallel-Group (Sponsor Open) Study to Assess Pharmacodynamics and Safety of PF-06865571 (DGAT2I) Co-Administered With PF-05221304 (ACCI) in Adult Participants with Presumed Nonalcoholic Steatohepatitis (NASH)
| Protocol | C3711005 |
|---|---|
| Identifier | |
| UID | c51d75c5-2903-4241-8c53-7461432fce95 |
| Status | Done - Archived |
| Phase | 2A |
| Category | / Adult |
| Launch Year | 2020 |
| NCT Number | - |
| Created | 2020-09-02 16:39 |
| Last Updated | 2022-07-19 18:31 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2021-12-31 | No |
| Enrollment Open | 2020-09-25 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2020-09-18 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2022-06-22 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Casaclang, Cecilia | CCasaclang | No |
| Recruiter | Miss, Salomon | SMiss | No |
| Coordinator | Diaz-Chavez, Mayra | MDiaz-Chavez | No |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Pfizer |
|---|---|
| Division | Pfizer |
| Team | Pfizer |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Syneos Health |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
